64 related articles for article (PubMed ID: 15062575)
1. Mixed lineage kinase 2 enhances trans-repression of Alien and nuclear receptors.
Eckey M; Tenbaum SP; Muñoz A; Baniahmad A
Mol Cell Endocrinol; 2003 Dec; 213(1):71-8. PubMed ID: 15062575
[TBL] [Abstract][Full Text] [Related]
2. Gene silencing by nuclear orphan receptors.
Zhang Y; Dufau ML
Vitam Horm; 2004; 68():1-48. PubMed ID: 15193450
[TBL] [Abstract][Full Text] [Related]
3. The tumor suppressors p33ING1 and p33ING2 interact with alien in vivo and enhance alien-mediated gene silencing.
Fegers I; Kob R; Eckey M; Schmidt O; Goeman F; Papaioannou M; Escher N; von Eggeling F; Melle C; Baniahmad A
J Proteome Res; 2007 Nov; 6(11):4182-8. PubMed ID: 17929852
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita.
Altincicek B; Tenbaum SP; Dressel U; Thormeyer D; Renkawitz R; Baniahmad A
J Biol Chem; 2000 Mar; 275(11):7662-7. PubMed ID: 10713076
[TBL] [Abstract][Full Text] [Related]
5. The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.
Choi KC; Oh SY; Kang HB; Lee YH; Haam S; Kim HI; Kim K; Ahn YH; Kim KS; Yoon HG
Biochem J; 2008 Apr; 411(1):19-26. PubMed ID: 18052923
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
7. The coregulator Alien.
Papaioannou M; Melle C; Baniahmad A
Nucl Recept Signal; 2007 Nov; 5():e008. PubMed ID: 18174916
[TBL] [Abstract][Full Text] [Related]
8. Human testicular orphan receptor 4 enhances thyroid hormone receptor signaling.
Huang YH; Liao CH; Chen RN; Liao CJ; Lin KH
J Cell Physiol; 2010 Feb; 222(2):347-56. PubMed ID: 19859911
[TBL] [Abstract][Full Text] [Related]
9. Corepressor recruitment by agonist-bound nuclear receptors.
White JH; Fernandes I; Mader S; Yang XJ
Vitam Horm; 2004; 68():123-43. PubMed ID: 15193453
[TBL] [Abstract][Full Text] [Related]
10. Dax-1 knockdown in mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation.
Khalfallah O; Rouleau M; Barbry P; Bardoni B; Lalli E
Stem Cells; 2009 Jul; 27(7):1529-37. PubMed ID: 19530134
[TBL] [Abstract][Full Text] [Related]
11. Gene silencing by the thyroid hormone receptor.
Eckey M; Moehren U; Baniahmad A
Mol Cell Endocrinol; 2003 Dec; 213(1):13-22. PubMed ID: 15062570
[TBL] [Abstract][Full Text] [Related]
12. Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily.
Dressel U; Thormeyer D; Altincicek B; Paululat A; Eggert M; Schneider S; Tenbaum SP; Renkawitz R; Baniahmad A
Mol Cell Biol; 1999 May; 19(5):3383-94. PubMed ID: 10207062
[TBL] [Abstract][Full Text] [Related]
13. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.
Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
J Mol Endocrinol; 2009 May; 42(5):415-28. PubMed ID: 19211732
[TBL] [Abstract][Full Text] [Related]
14. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
Zhou D; Chen B; Ye JJ; Chen S
Oncogene; 2004 Jul; 23(31):5394-404. PubMed ID: 15122321
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of adrenal absence: agenesis and aplasia.
Else T; Hammer GD
Trends Endocrinol Metab; 2005 Dec; 16(10):458-68. PubMed ID: 16275119
[TBL] [Abstract][Full Text] [Related]
16. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of RanBPM, a novel coactivator of thyroid hormone receptors.
Poirier MB; Laflamme L; Langlois MF
J Mol Endocrinol; 2006 Apr; 36(2):313-25. PubMed ID: 16595702
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of DAX1 action.
Iyer AK; McCabe ER
Mol Genet Metab; 2004; 83(1-2):60-73. PubMed ID: 15464421
[TBL] [Abstract][Full Text] [Related]
19. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
20. DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome, gene 1) selectively inhibits transactivation but not transrepression mediated by the glucocorticoid receptor in a LXXLL-dependent manner.
Zhou J; Oakley RH; Cidlowski JA
Mol Endocrinol; 2008 Jul; 22(7):1521-34. PubMed ID: 18417736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
